Sulfonylurea KATP blockade in type II diabetes and preconditioning in cardiovascular disease. Time for reconsideration.
Engler
R L
RL
Department of Medicine, Department of Veterans Affairs Medical Center, San Diego 92161, USA.
Yellon
D M
DM
D018528:ATP-Binding Cassette Transporters; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D006801:Humans; D019157:Ischemic Preconditioning, Myocardial; D026902:Potassium Channel Blockers; D015221:Potassium Channels; D024661:Potassium Channels, Inwardly Rectifying; D011955:Receptors, Drug / Q000037:antagonists & inhibitors*; D013453:Sulfonylurea Compounds / Q000037:antagonists & inhibitors; D064233:Sulfonylurea Receptors
D018528:ATP-Binding Cassette Transporters; D026902:Potassium Channel Blockers; D015221:Potassium Channels; D024661:Potassium Channels, Inwardly Rectifying; D011955:Receptors, Drug; D013453:Sulfonylurea Compounds; D064233:Sulfonylurea Receptors